BBOT vs GRALV
Comparison between BridgeBio Oncology Therapeutics Inc Com (BBOT, Company) and GRAIL Inc (GRALV, Company).
BBOT vs GRALV - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
BBOT
$674M
GRALV
$673M
Max Drawdown
BBOT
48.14%
Winner
GRALV
15.26%
Sharpe Ratio
BBOT
0.14
Winner
GRALV
7.16
5Y Beta
BBOT
1.26
GRALV
N/A
Industry
BBOT
Biotechnology
GRALV
N/A
P/E Ratio
Winner
BBOT
-5.02
GRALV
-3.30
Debt to Equity
BBOT
0.00%
GRALV
0.00%
Free Cash Flow Yield
Winner
BBOT
-11.77%
GRALV
-49.01%
P/S Ratio
BBOT
N/A
GRALV
4.75
P/B Ratio
BBOT
1.90
Winner
GRALV
0.30
BBOT vs GRALV - Historical Returns
Returns include dividend reinvestment.
1M
BBOT
+10.80%
GRALV
N/A
3M
BBOT
-7.82%
GRALV
N/A
6M
BBOT
-23.44%
GRALV
N/A
1Y
BBOT
-9.64%
GRALV
N/A
Max(CAGR)
BBOT
-10.23%
Winner
GRALV
+1264121.32%
BBOT vs GRALV - Annual Returns (2024 - 2026)
Returns include dividend reinvestment.
| Year | BBOT | GRALV |
|---|---|---|
| 2026 | -29.05% | N/A |
| 2025 | +29.74% | N/A |
| 2024 | N/A | +36.38% |
BBOT vs GRALV Drawdown Comparison
The maximum drawdown for BBOT was -48.14%, occurring on Jun 10, 2026. This drawdown has not yet recovered.
The maximum drawdown for GRALV was -15.26%, occurring on Jun 21, 2024. This drawdown has not yet recovered.
The current BBOT drawdown is -36.49%. The current GRALV drawdown is -8.32%.
| Rank | BBOT | GRALV |
|---|---|---|
| #1 | -48.14% Nov 17, 2025 - Jun 10, 2026 | -15.26% Jun 20, 2024 - Jun 21, 2024 |
| #2 | -26.82% Aug 18, 2025 - Sep 22, 2025 | N/A |
| #3 | -15.72% Oct 6, 2025 - Nov 10, 2025 | N/A |
| #4 | -6.99% Sep 22, 2025 - Oct 2, 2025 | N/A |
| #5 | -2.90% Nov 11, 2025 - Nov 14, 2025 | N/A |
| #6 | -0.64% Oct 2, 2025 - Oct 6, 2025 | N/A |
Correlation
Correlation between BBOT and GRALV is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
0.00
-101
Select Stocks to Compare
Popular: BBOT vs SPYGRALV vs SPY
More Comparisons
Compare with similar stocks